期刊文献+

组织血型抗原:轮状病毒可能的潜在受体 被引量:5

Histo-Blood Group Antigens: the Potential Receptor for the Rotaviruses
原文传递
导出
摘要 轮状病毒(RVs)是引起婴幼儿及动物非细菌性胃肠炎的重要病原体.研究发现,人类组织血型抗原(HBGAs)可能是RVs的结合受体.HBGAs具有丰富的多态性,包含ABO、分泌型及Lewis抗原.研究表明,不同P型的RVs与HBGAs的结合具有型特异性,而且不同人群对各型RVs易感性存在差异.因此,研究RVs与HBGAs的相互作用对于阐明RV感染的致病机理及RV疫苗的设计具有重要意义. Rotaviruses(RVs) are one of the most important pathogens for the viral gastroenteritis in human and animals. It is reported that histo-blood group antigens(HBGAs) may be the receptors and/or attachment factors for the RVs. HBGAs are highly polymorphic including ABO, secretor, and Lewis antigens. According to the previous studies, RVs of different P genotypes have been shown to interact with HBGAs in the genotype-dependent manner and there is various RVs susceptibility between different people. Therefore, the research of the interaction between RVs and HBGAs is significant to clarify the mechanism of RV pathogenesis and lays the foundation for the RV vaccine design.
出处 《中国科学:生命科学》 CSCD 北大核心 2015年第5期419-424,共6页 Scientia Sinica(Vitae)
基金 国家自然科学基金(批准号:81472003)资助项目
关键词 轮状病毒 组织血型抗原 VP8*蛋白 rotaviruses histo-blood group antigens VP8* protein
  • 相关文献

参考文献48

  • 1Parashar U D, Gibson C J, Bresee J S, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis, 2006, 12:304-306.
  • 2Tate J E, Burton A H, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis, 2012, 12: 136-141.
  • 3Kuhlenschmidt T B, Hanafin W P, Gelberg H B, et al. Sialic acid dependence and independence of group A rotaviruses. Adv Exp Med Biol, 1999, 473:309-317.
  • 4Ciarlet M, Estes M K. Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol, 1999, 80:943-948.
  • 5Huang P, Xia M, Tan M, et al. Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol, 2012, 86:4833-4843.
  • 6Liu Y, Huang P, Tan M, et al. Rotavirus VP8*: Phylogeny, host range, and interaction with histo-blood group antigens. J Virol, 2012, 86: 9899-9910.
  • 7Settembre E C, Chen J Z, Dormitzer P R, et al. Atomic model of an infectious rotavirus particle. EMBO J, 2011, 30:408-416.
  • 8Trask S D, Ogden K M, Patton J T. Interactions among capsid proteins orchestrate rotavirus particle functions. Curr Opin Virol, 2012, 2: 373-379.
  • 9Isa P, Realpe M, Romero P, et al. Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology, 2004, 322: 370-381.
  • 10Pesavento J B, Crawford S E, Roberts E, et al. pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol, 2005, 79:8572-8580.

同被引文献44

  • 1Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-assoclatedmortalily in children younger than 5 years before the introduction of universal tavirus vaccination prograrames: a systematic review and meta-analysis. Lancet Infect Dis, 2012, 12: 136-141.
  • 2Settembre EC, Chen JZ, Dorrnitzer PR, et al. Atomic model of an infectious rotavirus particle. EMBO J, 2011, 30: 408-416.
  • 3Padilla-Noriega L, Dunn SJ, Lopez S, Greenberg HB, Arias CF. 199. Identification of tv,'o independenneutralization domains on the VP4 trypsin cleavage products VP5 * and VP8 * of human rotavirus ST3. Virology, 206 : 148 -154.
  • 4Huang P, Xia M, Tan M, et al. Spike protein vp8 * of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol, 2012, 86: 4833-4843.
  • 5Vesikari T, Matson D O, Denneby P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 2006,354:23-33.
  • 6Ruiz-Palacios GM, Perez-Schael 1, Velazquez FR, ct al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med, 2006,354 : 1 1-22.
  • 7"Fate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate ofworldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccinati~m programmes: a systematic review and meta-analysis. Lancet Infect Dis, 2012, 12: 136-141.
  • 8Ruiz-Palacios G M, Perez-Schael I, Velazquez F R, et al. Safety and efficacy of an attenuated vaccine agains! severe rotaviras gastroenteritis. N Engl J Med, 2006,354 : 11-22.
  • 9Vesikari T, Matson D O, Dennehy P, et al. Safety and efficacy of a pentavatent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 2006,354:23-33.
  • 10Settembre E C, Chen J Z, Dormitzer P R, et al. Atomic mode| of an infectious rotavirus particle. EMBO J, 2011,30:408-416.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部